Comparative study on the treatment outcome and safety of TURP, ILC, TUNA and TEAP for patients with benign prostatic hyperplasia

Korean Journal of Urology

Volumn 47, Issue 1, 2006, Pages 13-19

  Kim, Taek Sang ^a   Choi, Seong ^a   Rhew, Hyun Yul ^a   Ahn, Jung Hwan ^a   Jang, Jin Ho ^a   Cho, Moon Hwan ^a  

^a Kosin University   (South Korea)

Author keywords

Benign prostatic hyperplasia; Safety; Treatment outcome

Indexed keywords

ALCOHOL;

ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EQUIPMENT DESIGN; ERECTILE DYSFUNCTION; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; LASER COAGULATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESIDUAL URINE; RETROGRADE EJACULATION; SCORING SYSTEM; SIDE EFFECT; TRANSURETHRAL NEEDLE ABLATION; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URETHRA STRICTURE; URINARY FREQUENCY; URINARY TRACT INFECTION; URINARY URGENCY; URINE FLOW RATE; URINE INCONTINENCE;

EID: 32444440212     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2006.47.1.13     Document Type: Article

References (21)

1. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132:474-9
2. Perrin P, Barnes R, Hadley H, Bergman RT. Forty years of transurethral prostatic resection. J Urol 1976;116:757-8
3. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243-7
4. Greenberger M, Steiner MS. The University of Tennessee experience with the Indigo 830e laser device for the minimally invasive treatment of benign prostatic hyperplasia: interim analysis. World J Urol 1998;16:386-91
5. Kim HH, Kwak C, Seo SI, Chung H, Lee ES, Lee CW. The effects and complications of transurethral resection for benign prostatic hyperplasia: results of long-term follow-up. Korean J Urol 1996;37:268-80
6. Mueller-Lisse UG, Heuck AF, Schneede P, Muschter R, Scheidler J, Hofstetter AG, et al. Postoperative MRI in patients undergoing interstitial laser coagulation thermotheraphy of benign prostatic hyperplasia. J Comput Assist Tomogr 1996; 20:273-8
7. Chandrasekar P, Virdi JS, Kapasi F. Interstitial laser ablation (Indigo®) of the prostate-a randomised prospective study, four year follow up. J Urol 2002;167(Suppl):294, abstract 1162
8. McNicholas TA, Steger AC, Bown SG. Interstitial laser coagulation of the prostate. An experimental study. Br J Urol 1993; 71:439-44
9. Williams JC. interstitial laser coagulation of the prostate. Tech Urol 1996;2:130-5
10. Calkins H, Langberg J, Sousa J, el-Atassi R, Leon A, Kou W, et al. Radiofrequency catheter ablation of accesory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome. Circulation 1992;85:1337-46
11. Organ LW. Electrophysiologic principles of radiofrequency lesion making. Appl Neurophysiol 1976;39:69-76
12. Ramon J, Lynch TH, Eardley I, Ekman P, Frick J, Jungwirth A, et al. Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: a collaborative multicenter study. Br J Urol 1997;80:128-35
13. Naslund MJ, Benson RJ, Cohen ES, Aceves JG, Issa MM. Transurethral needle ablation (TUNA) for BPH in patients with median lobe enlargement-report of a prospective multicenter study. J Urol 2000;163(Suppl):270, abstract 1198
14. Chandrasekar P, Virdi JS, Kapasi F. Transurethral needle ablation of the prostate (TUNA) in the treatment of benign prostatic hyperplasia: a prospective, randomised study, long term results. J Urol 2003;169(Suppl):468, abstract 1754
15. Livraghi T, Festi D, Monti F, Salmi A, Velotti C. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 1986;161:309-12
16. Solbiati L, Giangrande A, De Pra L, Bellotti E, Cantu P, Ravetto C. Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism. Radiology 1985;155:607-10
17. Zvara P, Karpman E, Stoppacher R, Esenler AC, Plante MK. Ablation of canine prostate using transurethral intraprostatic absolute ethanol injection. Urology 1999;54:411-5
18. Goya N, Ishikawa N, Ito F, Ryoji O, Tokumoto T, Toma H, et al. Ethanol injection therapy of the prostate for benign prostatic hyperplasia: preliminary report on application of a new technique. J Urol 1999;162:383-6
19. Aceves JG, Gilling P, Schettini M, Grise P, Sagarra JM, Hernandez C. Transurethral ethanol ablation of the prostate (TEAP), initial long term report of two prospective multicenter studies. J Urol 2003;169(Suppl):466, abstract 1747
20. Koo JH, Choi S, Rhew HY. The comparative study of interstitial laser coagulation and transurethral resection for benign prostatic hyperplasia. Korean J Urol 2000;41:1125-30
21. Schulman CC, Zlotta AR. Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: early clinical experience. Urology 1995;45:28-33